INTUITIVE SURGICAL INC (ISRG) Fundamental Analysis & Valuation

NASDAQ:ISRG • US46120E6023

Current stock price

452.07 USD
-12.38 (-2.67%)
At close:
454.29 USD
+2.22 (+0.49%)
After Hours:

This ISRG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. ISRG Profitability Analysis

1.1 Basic Checks

  • ISRG had positive earnings in the past year.
  • In the past year ISRG had a positive cash flow from operations.
  • In the past 5 years ISRG has always been profitable.
  • In the past 5 years ISRG always reported a positive cash flow from operatings.
ISRG Yearly Net Income VS EBIT VS OCF VS FCFISRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • The Return On Assets of ISRG (13.96%) is better than 94.68% of its industry peers.
  • The Return On Equity of ISRG (16.02%) is better than 90.43% of its industry peers.
  • ISRG has a better Return On Invested Capital (13.95%) than 94.68% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ISRG is above the industry average of 9.36%.
  • The last Return On Invested Capital (13.95%) for ISRG is above the 3 year average (12.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROIC 13.95%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ISRG Yearly ROA, ROE, ROICISRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of ISRG (28.38%) is better than 97.87% of its industry peers.
  • In the last couple of years the Profit Margin of ISRG has grown nicely.
  • ISRG's Operating Margin of 29.35% is amongst the best of the industry. ISRG outperforms 96.81% of its industry peers.
  • In the last couple of years the Operating Margin of ISRG has grown nicely.
  • ISRG's Gross Margin of 66.00% is fine compared to the rest of the industry. ISRG outperforms 72.34% of its industry peers.
  • ISRG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.35%
PM (TTM) 28.38%
GM 66%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
ISRG Yearly Profit, Operating, Gross MarginsISRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. ISRG Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ISRG is creating some value.
  • Compared to 1 year ago, ISRG has less shares outstanding
  • The number of shares outstanding for ISRG has been increased compared to 5 years ago.
  • ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ISRG Yearly Shares OutstandingISRG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ISRG Yearly Total Debt VS Total AssetsISRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • ISRG has an Altman-Z score of 38.47. This indicates that ISRG is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 38.47, ISRG belongs to the best of the industry, outperforming 97.34% of the companies in the same industry.
  • ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 38.47
ROIC/WACC1.33
WACC10.49%
ISRG Yearly LT Debt VS Equity VS FCFISRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • ISRG has a Current Ratio of 4.87. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ISRG (4.87) is better than 73.94% of its industry peers.
  • ISRG has a Quick Ratio of 3.96. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ISRG (3.96) is better than 72.34% of its industry peers.
Industry RankSector Rank
Current Ratio 4.87
Quick Ratio 3.96
ISRG Yearly Current Assets VS Current LiabilitesISRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ISRG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.83% over the past year.
  • The Earnings Per Share has been growing by 21.42% on average over the past years. This is a very strong growth
  • The Revenue has grown by 20.51% in the past year. This is a very strong growth!
  • Measured over the past years, ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 18.22% on average per year.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%

3.2 Future

  • Based on estimates for the next years, ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.58% on average per year.
  • ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.90% yearly.
EPS Next Y14.45%
EPS Next 2Y14.34%
EPS Next 3Y14.52%
EPS Next 5Y13.58%
Revenue Next Year15.88%
Revenue Next 2Y14.86%
Revenue Next 3Y14.57%
Revenue Next 5Y12.9%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ISRG Yearly Revenue VS EstimatesISRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
ISRG Yearly EPS VS EstimatesISRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

4

4. ISRG Valuation Analysis

4.1 Price/Earnings Ratio

  • ISRG is valuated quite expensively with a Price/Earnings ratio of 50.62.
  • Compared to the rest of the industry, the Price/Earnings ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 66.49% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.60, ISRG is valued quite expensively.
  • ISRG is valuated quite expensively with a Price/Forward Earnings ratio of 44.23.
  • Based on the Price/Forward Earnings ratio, ISRG is valued a bit cheaper than the industry average as 68.62% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 22.84. ISRG is valued rather expensively when compared to this.
Industry RankSector Rank
PE 50.62
Fwd PE 44.23
ISRG Price Earnings VS Forward Price EarningsISRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • ISRG's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 67.55% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 72.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 64.46
EV/EBITDA 41.82
ISRG Per share dataISRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ISRG does not grow enough to justify the current Price/Earnings ratio.
  • ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as ISRG's earnings are expected to grow with 14.52% in the coming years.
PEG (NY)3.5
PEG (5Y)2.36
EPS Next 2Y14.34%
EPS Next 3Y14.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ISRG Dividend Analysis

5.1 Amount

  • No dividends for ISRG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ISRG Fundamentals: All Metrics, Ratios and Statistics

INTUITIVE SURGICAL INC

NASDAQ:ISRG (4/2/2026, 8:00:02 PM)

After market: 454.29 +2.22 (+0.49%)

452.07

-12.38 (-2.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-21
Inst Owners88.53%
Inst Owner Change1.25%
Ins Owners0.45%
Ins Owner Change9.04%
Market Cap160.56B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts78.1
Price Target621.62 (37.51%)
Short Float %1.8%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)-0.46%
PT rev (3m)0.81%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)0.26%
EPS NY rev (1m)0%
EPS NY rev (3m)3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.45%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 50.62
Fwd PE 44.23
P/S 15.95
P/FCF 64.46
P/OCF 52.98
P/B 9.01
P/tB 9.21
EV/EBITDA 41.82
EPS(TTM)8.93
EY1.98%
EPS(NY)10.22
Fwd EY2.26%
FCF(TTM)7.01
FCFY1.55%
OCF(TTM)8.53
OCFY1.89%
SpS28.34
BVpS50.18
TBVpS49.09
PEG (NY)3.5
PEG (5Y)2.36
Graham Number100.42
Profitability
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROCE 16.01%
ROIC 13.95%
ROICexc 20.73%
ROICexgc 21.4%
OM 29.35%
PM (TTM) 28.38%
GM 66%
FCFM 24.75%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 79.72%
Cap/Sales 5.36%
Interest Coverage 250
Cash Conversion 83.46%
Profit Quality 87.21%
Current Ratio 4.87
Quick Ratio 3.96
Altman-Z 38.47
F-Score8
WACC10.49%
ROIC/WACC1.33
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
EPS Next Y14.45%
EPS Next 2Y14.34%
EPS Next 3Y14.52%
EPS Next 5Y13.58%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
Revenue Next Year15.88%
Revenue Next 2Y14.86%
Revenue Next 3Y14.57%
Revenue Next 5Y12.9%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year35.56%
EBIT Next 3Y21.57%
EBIT Next 5Y17.26%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%

INTUITIVE SURGICAL INC / ISRG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to ISRG.


What is the valuation status of INTUITIVE SURGICAL INC (ISRG) stock?

ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.


Can you provide the profitability details for INTUITIVE SURGICAL INC?

INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 9 / 10.


Can you provide the expected EPS growth for ISRG stock?

The Earnings per Share (EPS) of INTUITIVE SURGICAL INC (ISRG) is expected to grow by 14.45% in the next year.